Scientech Research LLC Has $678,000 Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Scientech Research LLC increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 12.6% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 7,769 shares of the medical device company’s stock after purchasing an additional 868 shares during the period. Scientech Research LLC’s holdings in Cooper Companies were worth $678,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its position in Cooper Companies by 3.0% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock valued at $682,738,000 after buying an additional 231,155 shares in the last quarter. Capital World Investors boosted its position in Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after buying an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC boosted its position in Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after buying an additional 2,532,186 shares in the last quarter. Finally, Impax Asset Management Group plc boosted its position in Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after buying an additional 558,886 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Buying and Selling

In related news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the sale, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at $700,422.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 over the last quarter. Insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $109.78 on Friday. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $112.38. The firm’s fifty day moving average is $99.84 and its 200-day moving average is $95.77. The firm has a market cap of $21.86 billion, a PE ratio of 64.58, a price-to-earnings-growth ratio of 2.63 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same quarter last year, the firm earned $0.84 earnings per share. Cooper Companies’s quarterly revenue was up 7.8% on a year-over-year basis. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on COO shares. Stifel Nicolaus restated a “buy” rating and issued a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and raised their target price for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Piper Sandler raised their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Morgan Stanley raised their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Finally, Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $115.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.